Terms: = Lung cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Staging
5 results:
1. Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial.
Felip E; Altorki N; Zhou C; Vallières E; Martínez-Martí A; Rittmeyer A; Chella A; Reck M; Goloborodko O; Huang M; Belleli R; McNally V; Srivastava MK; Bennett E; Gitlitz BJ; Wakelee HA
Ann Oncol; 2023 Oct; 34(10):907-919. PubMed ID: 37467930
[TBL] [Abstract] [Full Text] [Related]
2. [Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma].
Gao X; Li Z; Shao XY; Liu XM; Liu C; Liu YP; Qu XJ; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):569-573. PubMed ID: 34034477
[No Abstract] [Full Text] [Related]
3. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract] [Full Text] [Related]
4. The application of cryosurgery in the treatment of lung cancer.
Maiwand MO; Evans JM; Beeson JE
Cryobiology; 2004 Feb; 48(1):55-61. PubMed ID: 14969682
[TBL] [Abstract] [Full Text] [Related]
5. Cyfra 21-1 in diagnosis of distant metastases of head and neck carcinoma.
Hoffmann-Fazel A; Hoffmann M; Gottschlich S; Maass JD; Rudert H; Maune S
Anticancer Res; 2003; 23(2A):917-20. PubMed ID: 12820323
[TBL] [Abstract] [Full Text] [Related]
